Kepos Capital LP Kiromic Biopharma, Inc. Transaction History

Kepos Capital LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.87 $199,420 - $667,290	-767,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$4.81 - $10.34 $3.69 Million - $7.93 Million	767,000 New	767,000 $3.69 Million

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $14.6M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.